MAXZIDE-25
- Product NDC
- 0378-0464
- 11-digit product format
- 003780464
- Labeler code
- 0378
- Product ID
- 0378-0464_0e54ebec-df86-4205-9434-315913b56a94
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- maxzide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- NDA019129
- Marketing category
- NDA
- Marketing start
- 1988-05-13
- Marketing end
- 2024-03-31
- Substance
- HYDROCHLOROTHIAZIDE; TRIAMTERENE
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0378-0464-01 | 00378046401 | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0464-01) | 100 tablet | 1988-05-13 | 2024-03-31 | No | No | Current |